In addition, an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare data found that anti-TNF therapy increased the risk of certain cancers in older RA patients, particularly follicular lymphoma and the non-melanoma skin cancer (NMSC) and non-Hodgkin’s lymphoma (NHL) groups [17]. Here, TNF is linked to non-Hodgkin lymphoma.